Globalworld globe
United Kingdom
North America
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

Licensing deal for Penthrox in Australia

Jun 3, 2019Mark EdwardsNews

3 June 2019

ASX ANNOUNCEMENT

Licensing deal for Penthrox in Australia

Medical Developments International Limited (ASX: MVP) is delighted to announce it has reached agreement with Mundipharma Pty Ltd (Mundipharma) for the exclusive distribution rights of Penthrox® in Australia.

Mr. John Sharman, Chief Executive Officer of MVP, said: “This is an exciting deal for MVP because Mundipharma has a respected presence in the pain market with broad sales force coverage across Australia.  This presence in the field is expected to lead to impressive sales growth in the short to medium term, particularly within General Practitioner and Hospital channels.”

For the full announcement please click on the following link – ASX Announcement – Licensing deal for Penthrox in Australia

 

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Penthrox Marketing Authorisation Application in Russia

    6 December 2019 ASX ANNOU...

  • Penthrox IND approved in China

    21 November 2019 ASX ANNO...

  • MVP signs new Manufacturing Development Project with CSIRO

    29 October 2019 ASX ANNOU...

Healthcare Professional Registration

Login to access healthcare professional resources


Remember Me

Forgot password? | Register

Medical Developments International

Address: 4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: mdi@medicaldev.com
ABN: 14 106 340 667
For Medical Enquiries:
Phone: 1800 PENTHROX (1800 736 847)
Email: medinf@medicaldev.com

Email Newsletter

Sign up to our newsletter to receive MDI corporate, investor  & media news.